Its technology, developed by the company founders at MIT, combines biocompatible materials, 3D printing of axon mimics, and patient-derived human cells to generate remyelinating drugs for multiple sclerosis.Īnna Jagielska is its president, CEO, CSO and co-founder, while Kavin Kowsari is company vice president, CTO and co-founderĪtorvia Health Technologies, Ottawa, Canada Ītorvia’s purpose is to transform outcomes for patients with severe medical conditions. The line-upĪrtificial Axon Labs, Topsfield, MassachusettsĪrtificial Axon Labs is developing a drug discovery platform aimed at neurodegenerative diseases. The startups were selected following a rigorous vetting and interview process, led by a review board of industry leaders, said MassBio. The companies will also receive a stipend award from Bristol Myers Squibb (BMS) and access to and/or resources from MassBioDrive partners. Over the course of the eight-week program, the selected startups will participate in growth-focused business training taught by seasoned experts, and they will partner with a small, dedicated group of industry mentors. From simplifying CAR-T production to developing new therapeutics for acute kidney injury patients, the MassBioDrive spring cohort has enormous potential to address pressing unmet medical needs,” said Joe Boncore, CEO of MassBio. “The science and technologies that these companies are pioneering represent the future of the life sciences. The initiative, called MassBioDrive, looks to harness the power of the organization’s global life sciences network to help new founders launch their startups more effectively and efficiently. Since that time, it has moved on from simply being a register of companies that a single blog writes about to being a far broader business data repository.Īs I said, this space is highly competitive space, with incumbents and new entrants alike vying for mindshare - it will be interesting to see how Crunchbase applies this new investment and the results that it generates for them.The Massachusetts Biotechnology Council (MassBio) has just revealed the five emerging biotech companies chosen to participate in the spring 2022 cohort of its accelerator program.
#Syte crunchbase series#
The company got its start as the database of innovative companies underlying TechCrunch and spun out from AOL in September of 2015 with a Series A financing led by Emergence Capital. Crunchbase arguably has an advantage on the more traditional players by being internet-native, data driven and more agile - it’s hard for an organization that started as a newspaper-clipping service to quickly embrace the opportunity of the web.Ĭrunchbase's progression has been interesting to follow. In this aim, they’re not alone - a number of more traditional players, as well as innovative startups, are in this space as well. The big visionĬrunchbase wants to become what it calls the master record keeper for company data. The idea being that sales teams can closely follow investment trends, identify growing industries and identify companies that could be likely customers for their services.Ĭrunchbase already has a number of top-shelf organizations as customers, including Affinity, Datafox, Datanyze, Deloitte, Engagio, Everstring, Infer, Microsoft, Nestle, Samsung, Slack, Target, Volkswagen, and IBM Watson. Crunchbase Enterprise is a new offering for teams to access Crunchbase data, designed (as these things so often are) to be useful to sales personnel within an organization. The company (and I still find it hard to think of Crunchbase as a company, for me it has always been simply a destination site) is today announcing an $18 million Series B funding round, alongside a new paid service. Crunchbase’s basic product is free, while it also offers a number of premium (read: paid) solutions for higher-level purposes.
Crunchbase’s purpose in life is to surface information about companies - as someone who covers technology companies, Crunchbase is my go-to location for information about management, funding rounds and other relevant corporate data.Ĭrunchbase maintains a “master record” of corporate information, gathered from a wide variety of sources - contributors, partners and content teams. I’m a frequent visitor to the Crunchbase site.
0 kommentar(er)
